GDF15 and congestive heart failure: Studies have shifted focus toward novel biomarkers, such as soluble suppression of tumorigenicity 2 (sST2), high-sensitivity troponin, and growth differentiation factor 15 (GDF-15), which show promising prognostic capabilities in both acute and chronic heart failure settings (29, 30).